Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.280
-0.090 (-6.57%)
Jun 15, 2026, 4:00 PM EDT - Market closed

Pulmonx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
54922704913171,184
Market Cap Growth
-58.03%-65.91%-44.99%55.12%-73.27%-51.92%
Enterprise Value
48.7878.45224.88415.17199.631,031
Last Close Price
1.282.216.7912.758.4332.07
PS Ratio
0.611.023.227.155.9024.46
PB Ratio
1.181.703.154.152.066.13
EV/Sales Ratio
0.550.872.686.053.7221.29
Debt / Equity Ratio
1.201.020.650.320.140.13
Net Debt / Equity Ratio
-0.12-0.25-0.53-0.64-0.76-0.80
Net Debt / EBITDA Ratio
0.110.260.811.262.053.31
Net Debt / FCF Ratio
0.190.421.371.982.523.41
Asset Turnover
0.710.620.490.370.250.19
Inventory Turnover
1.101.231.150.920.760.95
Quick Ratio
3.844.094.705.598.1110.65
Current Ratio
4.915.075.586.509.1411.85
Return on Equity (ROE)
-106.55%-77.19%-55.25%-44.68%-33.94%-23.21%
Return on Assets (ROA)
-42.28%-37.17%-34.18%-33.66%-27.51%-19.10%
Return on Invested Capital (ROIC)
-128.90%-133.02%-139.41%-156.34%-152.77%-154.31%
Return on Capital Employed (ROCE)
-49.51%-43.34%-39.38%-37.56%-29.86%-20.18%
Buyback Yield / Dilution
-4.39%-4.03%-2.99%-2.37%-2.68%-254.74%
Total Shareholder Return
-4.39%-4.03%-2.99%-2.37%-2.68%-254.74%
SEC Filings: 10-K · 10-Q